Education
About Us
Working with TipRanks
Follow Us
Botanix Pharmaceuticals Limited (AU:BOT)
ASX:BOT
RESEARCH TOOLSreports
Total Valuation
Botanix Pharmaceuticals Limited has a market cap or net worth of AU$732.73M. The enterprise value is ―.
Market CapAU$732.73M
Enterprise Value―
Share Statistics
Botanix Pharmaceuticals Limited has 1,953,940,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,953,940,400
Owned by Insiders1.35%
Owned by Institutions―
Financial Efficiency
Botanix Pharmaceuticals Limited’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -14.22%.
Return on Equity (ROE)-0.13
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.22%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee54.71K
Profits Per Employee-1.26M
Employee Count11
Asset Turnover<0.01
Inventory Turnover5.91
Valuation Ratios
The current PE Ratio of Botanix Pharmaceuticals Limited is -34.10. Botanix Pharmaceuticals Limited’s PEG ratio is 0.15.
PE Ratio-34.10
PS Ratio0.00
PB Ratio9.14
Price to Fair Value4.35
Price to FCF-25.89
Price to Operating Cash Flow-24.19
PEG Ratio0.15
Income Statement
In the last 12 months, Botanix Pharmaceuticals Limited had revenue of 601.82K and earned -13.87M in profits. Earnings per share was -0.01.
Revenue601.82K
Gross Profit-6.55M
Operating Income-15.46M
Pretax Income-13.87M
Net Income-13.87M
EBITDA-13.92M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -34.93M and capital expenditures -167.05K, giving a free cash flow of -35.10M billion.
Operating Cash Flow-34.93M
Free Cash Flow-35.10M
Free Cash Flow per Share-0.02
Dividends & Yields
Botanix Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.96
52-Week Price Change35.71%
50-Day Moving Average0.42
200-Day Moving Average0.40
Relative Strength Index (RSI)39.06
Average Volume (3m)8.78M
Important Dates
Botanix Pharmaceuticals Limited upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Botanix Pharmaceuticals Limited as a current ratio of 22.21, with Debt / Equity ratio of 0.94%
Current Ratio22.21
Quick Ratio21.89
Debt to Market Cap0.00
Net Debt to EBITDA5.70
Interest Coverage Ratio-1.45K
Taxes
In the past 12 months, Botanix Pharmaceuticals Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Botanix Pharmaceuticals Limited EV to EBITDA ratio is -28.28, with an EV/FCF ratio of -15.07.
EV to Sales654.16
EV to EBITDA-28.28
EV to Free Cash Flow-15.07
EV to Operating Cash Flow-48.44
Balance Sheet
Botanix Pharmaceuticals Limited has AU$48.44M in cash and marketable securities with AU$866.35K in debt, giving a net cash position of -AU$47.57M billion.
Cash & Marketable SecuritiesAU$48.44M
Total DebtAU$866.35K
Net Cash-AU$47.57M
Net Cash Per Share-AU$0.02
Tangible Book Value Per ShareAU$0.05
Margins
Gross margin is -87.64%, with operating margin of -2568.82%, and net profit margin of -2304.63%.
Gross Margin-87.64%
Operating Margin-2568.82%
Pretax Margin-2304.63%
Net Profit Margin-2304.63%
EBITDA Margin-2312.88%
EBIT Margin-2302.86%
Analyst Forecast
The average price target for Botanix Pharmaceuticals Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.76%
EPS Growth Forecast-195.89%